Dr. Lynne Sykes, co-director of the March of Dimes Prematurity Research Center at Imperial College London, discusses her new paper detailing links between a woman’s blood type and her risk of spontaneous preterm birth depending on her gynecological and obstetrical history.

Dr. Wendy Kuohung, a 2025 March of Dimes Discovery Research Grant winner, discusses her original research to find novel therapeutics to treat preeclampsia associated with APOL1 gene variants.

Winners of the 2024 Nobel Prize in Physiology or Medicine Dr. Victor Ambros and Dr. Gary Ruvkun give a rare, extended joint interview about the road that led them to their discovery of miRNA in a roundworm, Dr. Ruvkun’s later discovery of miRNA in humans, how the scientists were both inspired at a young age by astronomy, what Dr. Ambros’ late father might have said about his son’s Nobel win, and a decades-old story from Dr. Ruvkun about a trip to Bolivia.

March of Dimes Chief Scientific Advisor Dr. Emre Seli and March of Dimes Senior Director of Research Operations Jonathan Cherry look back on MODCAST since its launch, and look forward to episodes in 2025.

Dr. Sam Mesiano, an investigator at the March of Dimes Ohio Collaborative Prematurity Research Center, discusses the enzyme that leads to progesterone withdrawal and labor in cases of infection-related preterm birth - and how this enzyme discovery can be used to revive progesterone therapy to delay or stop preterm birth.

Dr. Alexiane Decout, an assistant professor in immunology at the University of Warwick, and Dr. David MacIntyre, one of the directors of the March of Dimes Prematurity Research Center at Imperial College London, discuss the biological advantage of Lactobacillus Crispatus, the most in-demand of all vaginal microbiome bacteria, which is protective against preterm birth. Read the preprint here: https://www.biorxiv.org/content/10.1101/2024.09.13.612838v1.full

March of Dimes Senior Director of Research Operations Jonathan Cherry on March of Dimes research grants and awards.

Dr. Nima Aghaeepour, an investigator at the March of Dimes Prematurity Research Center at Stanford, and Dr. Sarah England, the director of the Center for Reproductive Health Sciences at Washington University School of Medicine, discuss a new Artificial Intelligence (AI) model that found that sleepers and movers have a 52% reduced risk of delivering early while those sleeping and moving less have a 44% increased risk of delivering early. 

The 2024 winners of the March of Dimes Basil O'Connor Starter Scholar Research Awards, Dr. Elizabeth Enninga and Dr. Mara Murray Horwitz, discuss their areas of study. Dr. Enninga, an Assistant Professor of Obstetrics & Gynecology, and Immunology, at Minnesota’s Mayo Clinic, explains how cell free (cf) fetal DNA triggers labor and preterm birth, and how understanding more about this process can help prevent early labor and more effectively induce labor. Dr. Murray Horwitz, a primary care doctor at Boston Medical Center and an assistant professor of medicine at Boston University, discusses barriers women with a hypertensive disorder of pregnancy (HDP), like preeclampsia, face in achieving cardiac and overall health after childbirth, and delves into an intervention called patient navigation that can lessen those barriers.

Dr. Alan Flake, the Director of the Center for Fetal Research at the Children’s Hospital of Philadelphia and 2021 March of Dimes Prize recipient, discusses the most impactful pursuits of his career: fetal surgery, the artificial womb, and in utero stem cell therapy.

Dr. Brice Gaudillière, an investigator at the March of Dimes Prematurity Research Center at Stanford University, discusses a breakthrough Machine Learning (ML) algorithm that makes reliable predictions about labor onset, preterm birth, and preeclampsia and also identifies the biological markers supporting those predictions.
 

Dr. Marisa Bartolomei, a University of Pennsylvania professor of cell and developmental biology, co-director of the university's Epigenetics Institute, and winner of the 2024 March of Dimes Richard B. Johnston, Jr., MD Prize, on discovering one of the first imprinted genes, making connections between imprinted gene mutations and developmental disorders, and uncovering the exact pathways of gene imprinting defects: namely, abnormalities in DNA methylation.

March of Dimes Research Center for Advancing Maternal Health Equity investigator Dr. Sindhu Srinivas and doula Alexia Doumbouya discuss leading a randomized controlled trial (RCT) on whether doula integration throughout pregnancy, birth, and postpartum can decrease maternal depression and anxiety.

Former Stanford PRC collaborator Dr. Jonas Miller, now a Psychological Sciences Assistant Professor at the University of Connecticut, discusses how the stress a woman experiences before pregnancy is associated with the way her child's brain functions around three to five years old. Those children, Dr. Miller found, have a harder time with impulse control.

Dr. Tim Hand, a March of Dimes researcher at the University of Pittsburgh, discusses the link between breast milk and a life-threatening preterm birth-related condition called necrotizing enterocolitis (NEC). As it turns out, not all breast milk is protective against NEC.

Dr. Elizabeth Cherot, the 6th and current President and CEO of March of Dimes, and the first medical doctor to lead the organization since its founding in 1938, discusses the March of Dimes Innovation Fund.

Dr. Lynne Sykes, a co-director of the March of Dimes Prematurity Research Center at Imperial College London, discusses the immune cascade that triggers vaginal microbiome-driven preterm birth and a new vaginal supplement that could change the makeup of the vaginal microbiome to prevent this type of immune response.

Philadelphia neonatologists Dr. Jay Greenspan and Dr. Liz Foglia discuss three talks at the upcoming Hot Topics in Neonatology conference in Maryland: one on the lower limits of viability and the other two on racism in the NICU.

Dr. Nima Aghaeepour, a researcher at March of Dimes' Prematurity Research Center at Stanford, discusses a Machine Learning (ML) model that predicts prematurity-related newborn diseases weeks before they occur, including before a baby is even born. 

Prof. MacIntyre, one of the directors of the March of Dimes Prematurity Research Center at Imperial College London, discusses his team's new device that can, in under two minutes, identify the type of bacteria in a woman's vaginal microbiome and determine whether it's causing inflammation, and could lead to preterm birth. 

Stanford University Science Fellow Dr. Mira Moufarrej on what we know about preeclampsia, why Black women in the U.S. are disproportionately impacted and a new blood test that could identify at-risk women in the first trimester. 

Dr. Marina Sirota, principal investigator at the March of Dimes Prematurity Research Center at the University of California San Francisco, and colleagues Dr. Tomiko Oskotsky and Dr. Jonathan Golob discuss using big data to launch a DREAM Challenge that succeeded in creating two predictive models for preterm birth risk.

March of Dimes Chief Scientific Officer Dr. Emre Seli discusses the motivations behind the podcast, the research vision at March of Dimes, our belief in open, collaborative science, and our focus on translational research that makes a difference for moms and babies. 

Dr. Lars Bode, the founding director of the Human Milk Institute at UC San Diego, the university’s Larsson-Rosenquist Foundation Chair of Collaborative Human Milk Research, and a professor of pediatrics at the university, discusses human milk, informally known as breast milk, and all its healing properties—that are not only crucial for mothers and babies, but may benefit people of all ages.

Prof. Dennis Lo, the winner of the 2025 March of Dimes Richard B. Johnston, Jr., MD Prize and the inventor of non-invasive prenatal testing, or NIPT, discusses the road to the discovery, the power of cell free DNA to detect cancer, and one of the places in the world he still hasn't been.

Dr. Tony Capra and Dr. Marina Sirota, scientists from the March of Dimes Prematurity Research Center (PRC) at the University of California, San Francisco (UCSF), discuss their foundational finding that spontaneous, or unplanned, preterm birth is fundamentally different from indicated preterm birth.

Dr. Diana Bianchi, a former March of Dimes Basil O’Connor Starter Scholar Research Award winner, discusses the ability of prenatal testing to detect maternal cancer, her discovery of microchimerism, a potential prenatal therapeutic for Down syndrome, and whether the subjects in Vermeer's paintings were pregnant. This episode was recorded March 4, 2025. As of the episode air date in May 2025, Dr. Bianchi no longer held the position of director of the National Institute of Child Health and Human Development (NICHD).

Leading micronutrient expert Dr. Kimberly O’Brien, a Professor of Human Nutrition at Cornell University and the 2025 recipient of the March of Dimes Agnes Higgins Award in Maternal-Fetal Nutrition, discusses what we know—and don't know—about iron requirements, metabolism, and use in pregnancy.

Dr. Phillip Bennett, a co-director of the March of Dimes Prematurity Research Center at Imperial College London, discusses a historic randomized controlled trial (RCT) that will test a vaginal probiotic's ability to reduce preterm birth risk.

Dr. Jamie Lo, an Associate Professor at Oregon Health & Science University, and Dr. Adam Crosland, an Assistant Professor at Oregon Health & Science University, discuss the risks of substance use, particularly cannabis, in pregnancy.

Dr. Ramkumar Menon, professor and director of the division of basic and translational research in obstetrics and gynecology at The University of Texas Medical Branch in Galveston and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses his career and focus at the PRC: pregnancy-on-a-chip technology that simulates human pregnancy and will be used to validate drugs that may reverse preterm birth.

Dr. Catherine Spong, professor and chair of the department of obstetrics and gynecology at UT Southwestern Medical Center in Dallas and one of two principal investigators at the new March of Dimes Texas Collaborative Prematurity Research Center, discusses her career, research, and focus at the PRC: examining how nutrition, socioeconomic factors, the placenta, and bacterial vaginosis affect pregnancy outcomes.

Dr. Tomiko Oskotsky, who co-directs The March of Dimes Database for Preterm Birth Research, discusses the database’s recent wins: being chosen for a National Science Foundation AI program and launching an AI assistant called ChatPTB, or ChatPreTermBirth.

Dr. Rupsa Boelig, a 2025 March of Dimes Discovery Research Grant winner and an Associate Professor of Obstetrics and Gynecology in the Division of Maternal Fetal Medicine at Philadelphia’s Thomas Jefferson University, discusses her new study on the metabolism of aspirin in pregnant women with diabetes or a higher BMI. She hopes the study findings will shed light on whether these women may benefit from a higher aspirin dose to help prevent preeclampsia and/or preterm birth.

Dr. Frank Lee, a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania Perelman School of Medicine and a 2026 winner of a March of Dimes Discovery Grant, discusses his research on HIF2 gene suppression as a way to treat preeclampsia.

Dr. Thomas Jansson, the 2026 winner of the March of Dimes Agnes Higgins Award in Maternal-Fetal Nutrition, the Vice Chair of Research for the University of Colorado Anschutz Department of Obstetrics and Gynecology and the department’s Florence Crozier Cobb Endowed Professor and Chief of the Division of Reproductive Sciences, discusses his research showing that contrary to popular belief, it is not the fetus, but a placental protein signaling hub called mTOR, that is the primary architect of fetal growth.

Dr. Leonard Zon, winner of the 2026 March of Dimes Richard B. Johnston, Jr., MD Prize, Director of the Stem Cell Research Program at Boston Children’s Hospital, and the Grousbeck Professor of Pediatric Medicine at Harvard Medical School, discusses his career using the 1.5-inch zebrafish to study human disease.